December 2009
- December 28, 2009
RADIENT PHARMA Informed By AMEX of Possible Delisting 
- December 18, 2009
RADIENT PHARMA Chinese Pharma Division Has Put In Place A Strategic Adivosry Agreement With Security Research Associates To Assist With The Sale or Financing of Jade Pharmaceutical
- December 3, 2009
Radient Pharmaceutical Corporation's Q309 Earnings Conference Call 
- December 1, 2009
RADIENT PHARMA Completes Registered Direct Offering For Approximately $1 Million
November 2009
- November 30, 2009
RADIENT PHARMA Reschedules Third Quarter 2009 Earnings Conference Call To Thursday December 3, 2009
- November 25, 2009
CEO, Douglas McLellan Interviewed on Steve Crowley's American Scene
- November 24, 2009
RADIENT PHARMA Announces Third Quarter 2009 Financial Results
- November 17, 2009
RADIENT PHARMA Files Extension For Third Quarter 2009 Financial Result
October 2009
- October 15, 2009
RADIENT PHARMA Signs Research Collaboration Agreement With CeTeCancer
- October 8, 2009
AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 ONKO-SURE™ Cancer Test
- October 6, 2009
RADIENT PHARMA Enters Into Distribution Agreement to Launch Sales of Onko-Sure IVD Cancer Test in Israel
September 2009
- September 29, 2009
RADIENT PHARMA Changes Corporate Name and Ticker Symbol Change
- September 19, 2009
AMDL Inc. Announces Stockholder Approval of Name Change & Issuance of a New Trading Symbol on The NYSE Alternext US.
August 2009
- August 21, 2009
AMDL Inc. Q209 Earnings Results Conference Call
- August 20, 2009
AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.
- August 19, 2009
AMDL Inc. Announces Second Quarter 2009 Financial Results
- August 14, 2009
AMDL Inc. Files Notification of Late Filing For Form 10-Q
July 2009
- July 8, 2009
AMDL Inc. Introduces New Brand Name For Its DR-70 (FDP) In Vitro
Diagnostic Cancer Test
June 2009
- June 17, 2009
AMDL Inc. CEO Featured in CEOCFO Magazine; Details Progress
on DR-70 International Commercialization Strategy & Confidence
in FY2009 Financial Forecast
May 2009
April 2009
- April 30, 2009
AMDL Inc. Signs First Customer Agreement With Precision Diagnostic
Laboratory For DR-70 (FDP) Cancer Test
- April 29, 2009
Chinese Pharma Market Continues To Grow At A 5-7% Rate in 2009;
AMDL Remains On Track To Meet FY09 Financial Targets
- April 16, 2009
AMDL Inc. Conference Call
- April 15, 2009
AMDL Inc. Reports 2008 Year End Financial Results and Fiscal
Year 2009 Targets
March 2009
- March 11, 2009
AMDL Inc. Enters Into Collaboration Agreement To Advance Development of Its AMDL DR-70 (FDP) Cancer Test
- March 6, 2009
Chinese Pharma Market Continues To Grow At A 5-7% Rate in 2009;
AMDL Remains On Track To Meet FY09 Financial Targets
February 2009
- February 4, 2009
AMDL Inc's. Chairman & CEO Mr. Douglas MacLellan Featured
on FOX Business News Wednesday, February 4, 2009
January 2009
- January 30, 2009
AMDL Inc. Announces Final Closing of Private Placement of Senior
Notes
- January 29, 2009
AMDL Inc. First To Implement US & China Based, GAAP Certified
Accounting Technology To Capitalize On Lucrative China Healthcare
Market
- January 27, 2009
AMDL Inc. Announces 2009 Financial Guidance and First Quarter
Objectives
- AMDL Inc. Chairman & CEO Announces Expert Opinion On China's
Economic Forecast
- AMDL 2009 Economic Forecast For China
- January 8, 2009
AMDL Inc. Completes Revision of Performance & Equity Incentive
Compensation Plan
- January 6, 2009
Rudd Report Gives AMDL Inc. Strong Buy Recommendation In Year-End
Financial Research Report
|
